Efficacy and Safety of MK-1293 Insulin Glargine Compared with Originator Insulin Glargine (Lantus) in Type 2 Diabetes (T2D)

Volume 2, Issue 13, Part 3.

Nestoras Mathioudakis, MD from Johns Hopkins interviews Dr. Marc Rendell from Creighton University School of Medicine about the study: Efficacy and Safety of MK-1293 Insulin Glargine Compared Along with Originator Insulin Glargine (Lantus) in Type 2 Diabetes, presented at the June 2016 American Diabetes Association Scientific Session.

A Patient-Centered Approach for Individualization of Pharmacotherapy in Obesity Care

Volume 2, Issue 13, Part 2.

Nestoras Mathioudakis, MD from Johns Hopkins interviews Dr. Jeffrey I. Mechanick from the Icahn School of Medicine at Mt. Sinai about his presentation: A Patient-Centered Approach for Individualization of Pharmacotherapy in Obesity Care, presented at the May 2016 AACE Annual Scientific and Clinical Congress.

Emerging Therapeutic Approaches for Chronic Hepatitis B

Volume 4, Issue 12.

Our guest author is Chloe Thio, MD, Professor of Medicine, Divison of Infectious Diseases at the Johns Hopkins University School of Medicine.

Take our post-test to claim CME credits:
Physician post-test
Nurse post-test

To read a companion newsletter click here.

Inpatient Glycemic Management: From the Bedside to the Cloud

Volume 2, Issue 13, Part 1.

Nestoras Mathioudakis, MD, MD from Johns Hopkins interviews Dr. Sethu Reddy from Cleveland Clinic about the seminar: Inpatient Glycemic Management: From Bedside to the Cloud presented at the May 2016 AACE Annual Scientific and Clinical Congress.